Cargando…

Outcomes after stereotactic radiosurgery of brain metastases in patients with malignant melanoma and validation of the melanoma molGPA

INTRODUCTION: Malignant melanoma is the third most common primary in the diagnosis of brain metastases. Stereotactic radiosurgery (SRS) is a well-established treatment option in limited brain disease. We analyzed outcomes of SRS with a particular focus on the graded prognostic assessment (GPA, melan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kessel, K. A., Deichl, A., Gempt, J., Meyer, B., Posch, C., Diehl, C., Zimmer, C., Combs, S. E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390419/ https://www.ncbi.nlm.nih.gov/pubmed/33993415 http://dx.doi.org/10.1007/s12094-021-02607-8

Ejemplares similares

Validation of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA)
por: Nieder, Carsten, et al.
Publicado: (2018)

A modified melanoma-molGPA scoring model: assessment of survival after and efficacy of different radiotherapy modalities in patients with melanoma brain metastases
por: Wu, Qian, et al.
Publicado: (2023)

Predictors of Lung Adenocarcinoma With Leptomeningeal Metastases: A 2022 Targeted-Therapy-Assisted molGPA Model
por: Zhang, Milan, et al.
Publicado: (2022)

Validation of the graded prognostic assessment for lung cancer with brain metastases using molecular markers (lung-molGPA)
por: Nieder, Carsten, et al.
Publicado: (2017)

Stereotactic radiosurgery for brain metastases from malignant melanoma
por: Christ, Sebastian M., et al.
Publicado: (2015)

Lung-molGPA Index Predicts Survival Outcomes of Non-Small-Cell Lung Cancer Patients with Synchronous or Metachronous Brain Metastases
por: Chen, Kaiyan, et al.
Publicado: (2020)

Linear accelerator-based stereotactic radiosurgery in 140 brain metastases from malignant melanoma
por: Hauswald, Henrik, et al.
Publicado: (2015)

Neoadjuvant stereotactic radiosurgery for intracerebral metastases of solid tumors (NepoMUC): a phase I dose escalation trial
por: Diehl, Christian D., et al.
Publicado: (2019)

Stereotactic Radiosurgery and Ipilimumab Versus Stereotactic Radiosurgery Alone in Melanoma Brain Metastases
por: Nguyen, Steven M, et al.
Publicado: (2017)

Applicability of the adjusted graded prognostic assessment for lung cancer with brain metastases using molecular markers (Lung‐molGPA) in a Chinese cohort: A retrospective study of multiple institutions
por: Zhang, Tingyou, et al.
Publicado: (2020)

Estimating Survival in Patients with Non-Small-Cell Lung Cancer and Brain Metastases: A Verification of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)
por: Li, Ji, et al.
Publicado: (2021)

Hypofractionated stereotactic radiotherapy (HFSRT) versus single fraction stereotactic radiosurgery (SRS) to the resection cavity of brain metastases after surgical resection (SATURNUS): study protocol for a randomized phase III trial
por: Waltenberger, Maria, et al.
Publicado: (2023)

Survival of melanoma patients with brain metastases treated with ipilimumab and stereotactic radiosurgery
por: Tazi, Karim, et al.
Publicado: (2015)

Stereotactic radiosurgery for the treatment of melanoma and renal cell carcinoma brain metastases
por: LWU, SHELLY, et al.
Publicado: (2013)

Stereotactic Radiosurgery With Concurrent Immunotherapy in Melanoma Brain Metastases Is Feasible and Effective
por: Liermann, Jakob, et al.
Publicado: (2020)

A Patient with HIV Treated with Ipilimumab and Stereotactic Radiosurgery for Melanoma Metastases to the Brain
por: Ruzevick, Jacob, et al.
Publicado: (2013)

Stereotactic radiosurgery for melanoma brain metastases: dose-size response relationship in the era of immunotherapy
por: Yusuf, Mehran, et al.
Publicado: (2021)

Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer)
por: Lesueur, Paul, et al.
Publicado: (2018)

RADI-32. INTRACRANIAL CONTROL AND RADIONECROSIS IN MELANOMA PATIENTS WITH BRAIN METASTASES TREATED WITH STEREOTACTIC RADIOSURGERY
por: Tjong, Michael, et al.
Publicado: (2019)

MMAP-10 ADVERSE RADIATION EFFECT AFTER STEREOTACTIC RADIOSURGERY AND IMMUNOTHERAPY/TARGETED THERAPY FOR MELANOMA BRAIN METASTASES
por: Phuong, Christina, et al.
Publicado: (2022)

A concise review of the efficacy of stereotactic radiosurgery in the management of melanoma and renal cell carcinoma brain metastases
por: Hanson, Peter W, et al.
Publicado: (2012)

Distant intracranial failure in melanoma brain metastases treated with stereotactic radiosurgery in the era of immunotherapy and targeted agents
por: Acharya, Sahaja, et al.
Publicado: (2017)

Robotic Stereotactic Radiosurgery in Melanoma Patients with Brain Metastases under Simultaneous Anti-PD-1 Treatment
por: Trommer-Nestler, Maike, et al.
Publicado: (2018)

Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity
por: Minniti, Giuseppe, et al.
Publicado: (2019)

Ipilimumab and Stereotactic Radiosurgery with CyberKnife(®) System in Melanoma Brain Metastases: A Retrospective Monoinstitutional Experience
por: Borzillo, Valentina, et al.
Publicado: (2021)

Stereotactic radiosurgery and stereotactic radiotherapy for brain metastases
por: Halasz, Lia M., et al.
Publicado: (2013)

RONC-17. STEREOTACTIC RADIOSURGERY FOR SPINE METASTASES IN PEDIATRIC MALIGNANCIES
por: Woodhouse, Kristina, et al.
Publicado: (2020)

Preoperative Stereotactic Radiosurgery for Brain Metastases
por: Routman, David M., et al.
Publicado: (2018)

Stereotactic Radiosurgery as Treatment for Brain Metastases: An Update
por: Peña-Pino, Isabela, et al.
Publicado: (2023)

Is local radiotherapy a viable option for patients with an opening of the ventricles during surgical resection of brain metastases?
por: Scharl, Sophia, et al.
Publicado: (2020)

The Judicious Use of Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy in the Management of Large Brain Metastases
por: Gutschenritter, Tyler, et al.
Publicado: (2020)

Stereotactic radiosurgery for melanoma brain metastases: Concurrent immune checkpoint inhibitor therapy associated with superior clinicoradiological response outcomes
por: Shanker, Mihir D, et al.
Publicado: (2022)

Postoperative Cavity Stereotactic Radiosurgery for Brain Metastases
por: Marchan, Eduardo M., et al.
Publicado: (2018)

Stereotactic radiosurgery combined with targeted/ immunotherapy in patients with melanoma brain metastasis
por: Hadi, Indrawati, et al.
Publicado: (2020)

Volume of Disease as a Predictor for Clinical Outcomes in Patients With Melanoma Brain Metastases Treated With Stereotactic Radiosurgery and Immune Checkpoint Therapy
por: Burke, Aidan M., et al.
Publicado: (2022)

SAFESTEREO: phase II randomized trial to compare stereotactic radiosurgery with fractionated stereotactic radiosurgery for brain metastases
por: Crouzen, J. A., et al.
Publicado: (2023)

Stereotactic Radiosurgery Results for Patients With Brain Metastases From Gastrointestinal Cancer: A Retrospective Cohort Study of 802 Patients With GI-GPA Validity Test
por: Yamamoto, Masaaki, et al.
Publicado: (2021)

Melanoma brain metastases treated with stereotactic radiosurgery and concurrent pembrolizumab display marked regression; efficacy and safety of combined treatment
por: Anderson, Erik S., et al.
Publicado: (2017)

Efficacy of BRAF Inhibitors in Combination With Stereotactic Radiosurgery for the Treatment of Melanoma Brain Metastases: A Systematic Review and Meta-Analysis
por: Khan, Muhammad, et al.
Publicado: (2021)

Factors Associated with Hemorrhage of Melanoma Brain Metastases after Stereotactic Radiosurgery in the Era of Targeted/Immune Checkpoint Inhibitor Therapies
por: Zoga, Eleni, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ekliho54kq78d7rpvjhg162ips